EUVIMEDEUVIMED entdecken
Crossref

Research Progress on LncRNA HCP5’s Regulation of Hypertrophic Scars by Targeting MiR-27b-3p

Jianping He, Lanzhe Xie, Zhuo Zhang, Peng Han

Skin Pharmacology and Physiology · 2025

DOI: 10.1159/000547809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skin Pharmacology and Physiology, 2025. Verfasst von Jianping He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Cicatrix, Hypertrophic, MicroRNAs. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypertrophic scars are common fibrotic disorders marked by fibroblast overgrowth and excessive extracellular matrix deposition, necessitating further research into their formation mechanisms to improve treatment outcomes. The study investigated the clinical significance and potential mechanisms of long noncoding RNA (lncRNA) HCP5 in the development of hypertrophic scars in human fibroblasts.

Methods

The study involved 63 patients to evaluate HCP5 expression through quantitative real-time PCR. Cellular behaviors of human hypertrophic scar myofibroblasts (HSFs) were measured using CCK-8, Transwell, and flow cytometry assays. Targeting interactions between lncRNA HCP5 and miR-27b-3p were verified using a dual-luciferase reporter assay.

Results

LncRNA HCP5 was significantly upregulated in hypertrophic scar tissue. More intriguingly, the silencing of lncRNA HCP5 led to a reduction in HSFs viability and migration, while simultaneously promoting apoptosis. Furthermore, miR-27b-3p was found to be downregulated and exhibited a negative correlation with lncRNA HCP5, both factors played crucial roles in regulating cellular behavior. In addition, the inhibition of miR-27b-3p may play a role in mitigating the effects induced by silenced lncRNA HCP5 on hypertrophic scars.

Conclusion

LncRNA HCP5 influenced the biological behavior of human hypertrophic scars by targeting miR-27b-3p.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingCicatrix, HypertrophicMicroRNAsHumansMaleFemaleCell MovementApoptosisFibroblastsAdultCells, CulturedMyofibroblastsCell SurvivalUp-Regulation

Stichwörter der Autor:innen

ApoptosisHypertrophic scarLncRNA HCP5MiR-27b-3p

Substanzen

RNA, Long NoncodingMicroRNAsHCP5 long noncoding RNA, humanMIRN27 microRNA, human

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Burn Department of Jinhua Central Hospital in Zhejiang Province, Jinhua, China.
  • Dermatology Department, First Clinical Medical College of Yunnan University of Chinese Medicine, Kunming, China.
  • Department of Plastic Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, China, hp15833218902@163.com.

Zitieren

APA

He, J., Xie, L., Zhang, Z., & Han, P. (2025). Research Progress on LncRNA HCP5’s Regulation of Hypertrophic Scars by Targeting MiR-27b-3p. Skin Pharmacology and Physiology. https://doi.org/10.1159/000547809

Vancouver

He J, Xie L, Zhang Z, Han P. Research Progress on LncRNA HCP5’s Regulation of Hypertrophic Scars by Targeting MiR-27b-3p. Skin Pharmacology and Physiology. 2025. doi:10.1159/000547809

BibTeX
@article{He2025,
  author = {He, Jianping and Xie, Lanzhe and Zhang, Zhuo and Han, Peng},
  title = {Research Progress on LncRNA HCP5’s Regulation of Hypertrophic Scars by Targeting MiR-27b-3p},
  journal = {Skin Pharmacology and Physiology},
  year = {2025},
  doi = {10.1159/000547809}
}
Kostenlos starten →